These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 3930323
1. Effects of gastric inhibitory polypeptide in the response to prolonged parenteral or enteral alimentation in rats. Baer AR, Dupre J. Diabetes; 1985 Nov; 34(11):1108-12. PubMed ID: 3930323 [Abstract] [Full Text] [Related]
2. Suppression of insulin receptor binding by prolonged enteral or parenteral nutrient infusion in the rat: role of gastric inhibitory polypeptide. Baer AR, Dupré J. Can J Physiol Pharmacol; 1989 Sep; 67(9):1105-9. PubMed ID: 2513110 [Abstract] [Full Text] [Related]
3. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224 [Abstract] [Full Text] [Related]
4. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Osei K, Falko JM, O'Dorisio TM, Adam DR. Diabetes Care; 1985 Feb; 8(5):436-9. PubMed ID: 3902421 [Abstract] [Full Text] [Related]
5. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L. J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154 [Abstract] [Full Text] [Related]
6. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R. J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629 [Abstract] [Full Text] [Related]
7. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs. Pierluissi J, de Pierluissi R, de Martínez A. Acta Cient Venez; 2002 Jul; 53(1):29-35. PubMed ID: 12216497 [Abstract] [Full Text] [Related]
8. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man. Füessl HS, Yiangou Y, Ghatei MA, Goebel FD, Bloom SR. Eur J Clin Invest; 1990 Oct; 20(5):525-9. PubMed ID: 2124984 [Abstract] [Full Text] [Related]
9. The hepatic extraction of gastric inhibitory polypeptide and insulin. Hanks JB, Andersen DK, Wise JE, Putnam WS, Meyers WC, Jones RS. Endocrinology; 1984 Sep; 115(3):1011-8. PubMed ID: 6378600 [Abstract] [Full Text] [Related]
10. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus. Ross SA, Brown JC, Dupré J. Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834 [Abstract] [Full Text] [Related]
18. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia. Dupre J, Caussignac Y, McDonald TJ, Van Vliet S. J Clin Endocrinol Metab; 1991 Jan; 72(1):125-9. PubMed ID: 1986010 [Abstract] [Full Text] [Related]
19. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon. Ebert R, Arnold R, Creutzfeldt W. Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672 [Abstract] [Full Text] [Related]
20. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin. Meneilly GS, Ryan AS, Minaker KL, Elahi D. J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971 [Abstract] [Full Text] [Related] Page: [Next] [New Search]